Cargando…
Mesenteric Fibromatosis in Crohn's Disease as a Potential Effect of Adalimumab
A 36-year-old woman with no medical or surgical history was evaluated for weight loss. Abdominal computed tomography (CT) showed signs of Crohn's disease, which was later confirmed endoscopically. She was started on tumor necrosis factor-α (TNF-α) inhibitor therapy. Nine months after treatment,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Gastroenterology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843151/ https://www.ncbi.nlm.nih.gov/pubmed/27144199 http://dx.doi.org/10.14309/crj.2016.44 |